MacRae H M, Yakimets W W, Reynolds T
Department of Surgery, University of Alberta, Edmonton.
Can J Surg. 1992 Aug;35(4):432-6.
A 15-year study of perioperative complications was carried out in 142 adults who underwent splenectomy for hematologic disease at the University of Alberta Hospital in order to obtain recent statistics on morbidity and mortality. The patients were grouped into four diagnostic categories: idiopathic thrombocytopenic purpura (71 patients), lymphoproliferative disorders (34 patients), myeloproliferative disorders (12 patients) and miscellaneous disorders (25 patients). Splenectomy was carried out for therapeutic reasons in 93% of patients and to establish a diagnosis in 7%. The overall complication rate was 22% (31 of 142) and the death rate was 6% (7 of 142). Infection accounted for 42% of the complications. Steroid or antibiotic therapy preoperatively did not significantly affect the infection rate. Drains, if removed within the first week, also did not affect the postoperative infection rate. Spleen size and the interaction between diagnosis and the presence of thrombocytopenia were predictors of the need for intraoperative transfusion.
对142例在阿尔伯塔大学医院因血液病接受脾切除术的成年人进行了一项为期15年的围手术期并发症研究,以获取近期关于发病率和死亡率的统计数据。患者被分为四个诊断类别:特发性血小板减少性紫癜(71例患者)、淋巴增殖性疾病(34例患者)、骨髓增殖性疾病(12例患者)和其他疾病(25例患者)。93%的患者因治疗原因进行脾切除术,7%的患者是为了明确诊断。总体并发症发生率为22%(142例中的31例),死亡率为6%(142例中的7例)。感染占并发症的42%。术前使用类固醇或抗生素治疗对感染率没有显著影响。引流管如果在第一周内拔除,也不会影响术后感染率。脾脏大小以及诊断与血小板减少症之间的相互作用是术中输血需求的预测因素。